<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>LUFYLLIN- dyphylline tablet </strong><br>Meda Pharmaceuticals Inc.<br></p></div>
<h1>
<span class="Bold">Lufyllin<span class="Sup">®</span><br>(dyphylline tablets, USP, 200 mg)<br><br>Lufyllin<span class="Sup">®</span>-400<br>(dyphylline tablets, USP, 400 mg)<br><br></span>IN-0521-11    Rev. 1/09</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="b434-0002a5d5c51bjt-1"></a><a name="section-1"></a><p></p>
<h1>Description</h1>
<p class="First">LUFYLLIN (dyphylline), a xanthine derivative, is a bronchodilator available for oral administration as tablets containing 200 mg and 400 mg of dyphylline. Other ingredients: magnesium stearate, microcrystalline cellulose.</p>
<p>Chemically, dyphylline is 7-(2,3-dihydroxypropyl)-theophylline, a white, extremely bitter, amorphous powder that is freely soluble in water and soluble in alcohol to the extent of 2 g/100 mL. Dyphylline forms a neutral solution that is stable in gas­trointestinal fluids over a wide range of pH.</p>
<p>The molecular formula for dyphylline is C<span class="Sub">10</span>H<span class="Sub">14</span>N<span class="Sub">4</span>O<span class="Sub">4</span> with a molecular weight of 254.25. Its structural formula is:</p>
<p><img alt="Dyphylline Molecular Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b&amp;name=lufyllin-figure-1.jpg"></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="a56f-0002a5d5c51bjt-2"></a><a name="section-2"></a><p></p>
<h1>Clinical Pharmacology</h1>
<p class="First">Dyphylline is a xanthine derivative with pharmacologic actions similar to theophylline and other members of this class of drugs. Its primary action is that of bronchodilation, but it also exhibits peripheral vasodilatory and other smooth muscle relaxant activity to a lesser degree. The bronchodilatory action of dyphylline, as with other xanthines, is thought to be mediated through competitive inhibition of phosphodiesterase with a resulting increase in cyclic AMP producing relaxation of bronchial smooth muscle.</p>
<p>LUFYLLIN is well tolerated and produces less <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> than aminophylline and other alkaline theophylline compounds when administered orally. Unlike the hydrolyzable salts of theophylline, dyphylline is not converted to free theophylline <span class="Italics">in vivo</span>. It is absorbed rapidly in therapeutically active form and in healthy volunteers reaches a mean peak plasma concentration of 17.1 mcg/mL in approximately 45 minutes following a single oral dose of 1000 mg of LUFYLLIN.</p>
<p>Dyphylline exerts its bronchodilatory effects directly and, unlike the­ophylline, is excreted unchanged by the kidneys without being metabolized by the liver. Because of this, dyphylline pharmacokinetics and plasma levels are not influenced by various factors that affect liver function and hepatic enzyme activity, such as smoking, age, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, or concomitant use of drugs which affect liver function.</p>
<p>The elimination half-life of dyphylline is approximately two hours (1.8-2.1 hr) and approximately 88% of a single oral dose can be recovered from the urine unchanged. The renal clearance would be correspondingly reduced in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. In anuric patients, the half-life may be increased 3 to 4 times normal.</p>
<p>Dyphylline plasma levels are dose-related and generally predictable. The range of plasma levels within which dyphylline can be expected to produce effective bronchodilation has not been determined.</p>
<p>Dyphylline plasma concentrations can be accurately determined using high pressure liquid chromatography (HPLC) or gas-liquid chromatography (GLC).</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="a60f6f00-9646-11dejt-3"></a><a name="section-3"></a><p></p>
<h1>Indications and Usage</h1>
<p class="First">For relief of acute bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span> and for reversible <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span> associated with <span class="product-label-link" type="condition" conceptid="255841" conceptname="Chronic bronchitis">chronic bronchitis</span> and <span class="product-label-link" type="condition" conceptid="4169883" conceptname="Emphysema">emphysema</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="a58d-0002a5d5c51bjt-4"></a><a name="section-4"></a><p></p>
<h1>Contraindications</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to dyphylline or related xanthine compounds.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="b3c8-0002a5d5c51bjt-5"></a><a name="section-5"></a><p></p>
<h1>Warnings</h1>
<p class="First">LUFYLLIN is not indicated in the management of status asthmaticus, which is a serious medical emergency.</p>
<p>Although the relationship between plasma levels of dyphylline and appearance of toxicity is unknown, excessive doses may be expected to be associated with an increased risk of adverse effects.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="a944-0002a5d5c51bjt-6"></a><a name="section-6"></a><p></p>
<h1>Precautions</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="b489-0002a5d5c51bjt-6-1"></a><a name="section-6.1"></a><p></p>
<p class="First"><span class="Italics">General: </span>Use LUFYLLIN with caution in patients with severe cardiac disease, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, acute myocardial injury, or <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="aebf-0002a5d5c51bjt-6-2"></a><a name="section-6.2"></a><p></p>
<p class="First"><span class="Italics">Drug interactions: </span>Synergism between xanthine bronchodilators (e.g., theophylline), ephedrine, and other sympathomimetic bronchodilators has been reported. This should be considered whenever these agents are prescribed concomitantly.</p>
<p>Concurrent administration of dyphylline and probenecid, which competes for tubular secretion, has been shown to increase the plasma half-life of dyphylline (see <a href="#a56f-0002a5d5c51bjt-2">Clinical Pharmacology</a>).</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="b8fa-0002a5d5c51bjt-6-3"></a><a name="section-6.3"></a><p></p>
<p class="First"><span class="Italics">Carcinogenesis, mutagenesis, impairment of fertility: </span>No long-term animal studies have been performed with LUFYLLIN.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="a1cbd0e0-9651-11dejt-6-4"></a><a name="section-6.4"></a><p></p>
<p class="First"><span class="Italics">Pregnancy: </span>Teratogenic effects — Pregnancy Category C. Animal reproduction studies have not been conducted with LUFYLLIN. It is also not known if LUFYLLIN can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. LUFYLLIN should be given to a pregnant woman only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="a2a0-0002a5d5c51bjt-6-5"></a><a name="section-6.5"></a><p></p>
<p class="First"><span class="Italics">Nursing mothers: </span>Dyphylline is present in human milk at approximately twice the maternal plasma concentration. Caution should be exercised when LUFYLLIN is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="b524-0002a5d5c51bjt-6-6"></a><a name="section-6.6"></a><p></p>
<p class="First"><span class="Italics">Pediatric use: </span>Safety and effectiveness in children have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="a7e3-0002a5d5c51bjt-6-7"></a><a name="section-6.7"></a><p></p>
<p class="First"><span class="Italics">Geriatric use: </span>Clinical studies of LUFYLLIN did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="a5cc-0002a5d5c51bjt-7"></a><a name="section-7"></a><p></p>
<h1>Adverse Reactions</h1>
<p class="First"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-800-526-3840 or FDA at 1-800-FDA-1088 or <span class="Italics Underline">www.fda.gov/medwatch</span>.</span></p>
<p>Adverse reactions with the use of LUFYLLIN have been infrequent, relatively mild, and rarely required reduction in dosage or withdrawal of therapy.</p>
<p>The following adverse reactions which have been reported with other xanthine bronchodilators, and which have most often been related to excessive drug plasma levels, should be considered as potential adverse effects when dyphylline is administered:</p>
<p><span class="Italics">Gastrointestinal: </span><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">epigastric pain</span>, <span class="product-label-link" type="condition" conceptid="26727" conceptname="Hematemesis">hematemesis</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>.</p>
<p><span class="Italics">Central nervous system: </span><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">hyperexcitability</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="4247265" conceptname="Muscle twitch">muscle twitching</span>, generalized clonic and <span class="product-label-link" type="condition" conceptid="4198075" conceptname="Tonic seizure">tonic convulsions</span>.</p>
<p><span class="Italics">Cardiovascular: </span><span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316429" conceptname="Premature beats">extrasystoles</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">circulatory failure</span>, <span class="product-label-link" type="condition" conceptid="4185572" conceptname="Ventricular arrhythmia">ventricular arrhythmias</span>.</p>
<p><span class="Italics">Respiratory: </span><span class="product-label-link" type="condition" conceptid="317376" conceptname="Tachypnea">tachypnea</span>.</p>
<p><span class="Italics">Renal: </span><span class="product-label-link" type="condition" conceptid="4168705" conceptname="Albuminuria">albuminuria</span>, gross and <span class="product-label-link" type="condition" conceptid="75004" conceptname="Frank hematuria">microscopic hematuria</span>, <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span>.</p>
<p><span class="Italics">Other: </span><span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>, <span class="product-label-link" type="condition" conceptid="4207539" conceptname="Syndrome of inappropriate vasopressin secretion">inappropriate ADH</span> syndrome.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="a594-0002a5d5c51bjt-8"></a><a name="section-8"></a><p></p>
<h1>Overdosage</h1>
<p class="First">There have been no reports, in the literature, of overdosage with LUFYLLIN. However, the following information based on reports of theophylline overdosage are considered typical of the xanthine class of drugs and should be kept in mind.</p>
<p><span class="Italics">Signs and symptoms: </span><span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">Restlessness</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, and <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>. Marked overdosage with resulting severe toxicity has produced <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, severe <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, <span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">excessive thirst</span>, <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="4178904" conceptname="Body temperature above reference range">hyperthermia</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">diaphoresis</span>, and generalized clonic and <span class="product-label-link" type="condition" conceptid="4198075" conceptname="Tonic seizure">tonic convulsions</span>. <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">Cardiovascular collapse</span> has also occurred, with some fatalities. <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Seizures</span> have occurred in some cases associated with very high theophylline plasma concentrations, without any premonitory symptoms of toxicity.</p>
<p><span class="Italics">Treatment: </span>There is no specific antidote for overdosage with drugs of the xanthine class. Symptomatic treatment and general supportive measures should be instituted with careful monitoring and maintenance of vital signs, fluids, and electrolytes. The stomach should be emptied by inducing <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> if the patient is conscious and responsive, or by gastric lavage, taking care to protect against <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span>, especially in stuporous or <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">comatose</span> patients. Maintenance of an adequate airway is essential in case oxygen or assisted respiration is needed. Sympathomimetic agents should be avoided but sedatives such as short-acting barbiturates may be useful.</p>
<p>Dyphylline is dialyzable and, although not recommended as a routine procedure in overdosage cases, hemodialysis may be of some benefit when severe <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> is present or when the patient has not responded to general supportive and symptomatic treatment.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="af4d-0002a5d5c51bjt-9"></a><a name="section-9"></a><p></p>
<h1>Dosage and Administration</h1>
<p class="First">Dosage should be individually titrated according to the severity of the condition and the response of the patient.</p>
<p><span class="Italics">Usual adult dosage: </span>Up to 15 mg/kg every six hours.</p>
<p>Appropriate dosage adjustments should be made in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span> (see <a href="#a56f-0002a5d5c51bjt-2">Clinical Pharmacology</a>).</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="a1237100-9653-11dejt-10"></a><a name="section-10"></a><p></p>
<h1>How Supplied</h1>
<p class="First">LUFYLLIN Tablets contain 200 mg dyphylline and are white, rectangular, scored on one side and imprinted WALLACE 521 on the other side. The tablets are available in bottles of 100 (NDC 0037-0521-92).</p>
<p>LUFYLLIN-400 Tablets contain 400 mg dyphylline and are white, capsule-shaped, scored on one side and imprinted WALLACE 731 on the other side. The tablets are available in bottles of 100 (NDC 0037-0731-92).</p>
<p><span class="Italics">Storage: </span>Store at controlled room temperature 20°-25°C (68°-77°F).</p>
<p>Dispense in a tight container.</p>
<p><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-800-526-3840 or FDA at 1-800-FDA-1088 or <span class="Italics Underline">www.fda.gov/medwatch</span>.</span></p>
<p><span class="Bold">Meda Pharmaceuticals</span></p>
<p><span class="Bold">Meda Pharmaceuticals Inc.</span><br>Somerset, New Jersey 08873-4120</p>
<p>Printed in U.S.A.    Rev. 1/09<br>IN-0521-11</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ad70-0002a5d5c51bjt-11"></a><a name="section-11"></a><p></p>
<h1>Package Label - Principal Display Panel – 100-Count Bottle, 200 mg Tablets</h1>
<p class="First">NDC 0037-0521-92<br>100 Tablets<br><span class="Bold">Lufyllin<span class="Sup">®</span></span><br>(dyphylline tablets, USP)<br>200 mg<br><span class="Bold">Rx Only<br>Meda Pharmaceuticals</span><br>LB-052103-07       Rev. 8/07<br><span class="Bold">Usual Dosage:  </span>See package insert.<br>Store at controlled room temperature 20°-25°C (68°-77°F)<br>Dispense in a tight container<br><span class="Bold">Meda Pharmaceuticals</span><br>Meda Pharmaceuticals Inc.<br>Somerset, New Jersey 08873-4120</p>
<p><img alt="100-Count Bottle, 200 mg Tablets" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b&amp;name=lufyllin-figure-2.jpg"></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="bf9c-0002a5d5c51bjt-12"></a><a name="section-12"></a><p></p>
<h1>Package Label - Principal Display Panel – 100-Count Bottle, 400 mg Tablets</h1>
<p class="First">NDC 0037-0731-92<br>100 Tablets<br><span class="Bold">Lufyllin<span class="Sup">®</span> - 400</span><br>(dyphylline tablets, USP)<br>400 mg<br><span class="Bold">Rx Only<br>Meda Pharmaceuticals</span><br>LB-073103-07       Rev. 8/07<br><span class="Bold">Usual Dosage:  </span>See package insert<br>Store at controlled room temperature 20°-25°C (68°-77°F)<br>Dispense in a tight container<br><span class="Bold">Meda Pharmaceuticals</span><br>Meda Pharmaceuticals Inc.<br>Somerset, New Jersey 08873-4120</p>
<p><img alt="100-Count Bottle, 400 mg Tablets" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b&amp;name=lufyllin-figure-3.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>LUFYLLIN 		
					</strong><br><span class="contentTableReg">dyphylline tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0037-0521</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DYPHYLLINE</strong> (DYPHYLLINE) </td>
<td class="formItem">DYPHYLLINE</td>
<td class="formItem">200 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">RECTANGLE</td>
<td class="formLabel">Size</td>
<td class="formItem">11mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">WALLACE;521</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0037-0521-92</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA084566</td>
<td class="formItem">08/31/1976</td>
<td class="formItem">02/29/2016</td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>LUFYLLIN 		
					</strong><br><span class="contentTableReg">dyphylline tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0037-0731</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DYPHYLLINE</strong> (DYPHYLLINE) </td>
<td class="formItem">DYPHYLLINE</td>
<td class="formItem">400 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE</td>
<td class="formLabel">Size</td>
<td class="formItem">15mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">WALLACE;731</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0037-0731-92</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA084566</td>
<td class="formItem">08/31/1976</td>
<td class="formItem">01/31/2015</td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Meda Pharmaceuticals Inc.
							(051229602)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 1/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>dbe7c29c-bdbc-422f-94e6-d23c415cf473</div>
<div>Set id: 6d7ed7c0-9646-11de-a404-0002a5d5c51b</div>
<div>Version: 4</div>
<div>Effective Time: 20150112</div>
</div>
</div> <div class="DistributorName">Meda Pharmaceuticals Inc.</div></p>
</body></html>
